The legal landscape and requirements for a life sciences company to fundraise in the US are a nightmare, to put it gently. Guidelines changed recently with the Jumpstart Our Business Startups (JOBS) Act, and the sheer number of investment strategies for a life science startup executive to understand and pursue are staggering. Add in outdated tactics and dried up bank accounts of traditional venture capitalists (VCs), and many in the life sciences field are left jaded and skeptical about fundraising completely. Or, as Life Science Nation (LSN) Founder Dennis Ford puts it, “When I started my company, I spent 18 months traveling around the world going to tons of investor conferences, but real investors were nowhere to be found. The VCs in this space just couldn’t get any returns and no longer have the money we need.”…